Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients–a pilot study for novel biomarker and risk stratification …

SVW Schulz, DA Bizjak, E Moebes, L John… - Frontiers in …, 2023 - frontiersin.org
Background Low aerobic capacity is associated with an increased mortality risk in allogenic
stem-cell transplantation (alloSCT) patients, but currently used risk scores in the pre …

Молекулярные механизмы “цитокинового шторма” при острых инфекционных заболеваниях

МВ Шипилов - Лечебное дело, 2013 - cyberleninka.ru
Описана клиническая картина “цитокинового шторма” на примере последствий
введения экспериментального препарата TGN1412 здоровым волонтерам в марте …

Prevention of GVHD without losing GVL effect: windows of opportunity

P Zhang, BJ Chen, NJ Chao - Immunologic research, 2011 - Springer
Allogeneic hematopoietic cell transplantation has developed into a most successful form of
immunotherapy for hematologic malignancies in the past 50 years. However, its …

Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein–Barr virus and bacterial …

CF Classen, PI Bird, KM Debatin - Clinical & Experimental …, 2006 - academic.oup.com
Summary Proteinase inhibitor 9 (PI-9) is an intracellular serpin expressed in lymphocytes
and monocyte-derived cells. It is the only known endogenous natural antagonist of …

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation

M Döring, KM Cabanillas Stanchi, M Mezger… - BMC cancer, 2015 - Springer
Abstract Background Veno-occlusive disease, Graft-versus-Host disease, invasive or
localized bacterial, viral and fungal infections are known as adverse events after …

Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients

M Döring, KM Cabanillas Stanchi, J Feucht… - Annals of …, 2016 - Springer
Diagnosis of adverse events following hematopoietic stem cell transplantation (HSCT) is
mainly assigned to clinical symptoms or biopsies and thus rather unspecific and/or invasive …

Pediatric cutaneous graft versus host disease: a review

CR Shi, JT Huang, VE Nambudiri - Current pediatric reviews, 2017 - ingentaconnect.com
Background: Graft versus host disease (GVHD) is a significant complication following
hematopoietic stem cell transplantation in the pediatric population. The most common …

Increased donor CD86+ CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease

M Arpinati, G Chirumbolo, G Marzocchi… - …, 2008 - journals.lww.com
Background. Based on experimental models, chronic graft-versus-host disease (cGVHD)
may depend on activated donor antigen-presenting cells presenting host antigens to donor …

Chronic graft-versus-host disease in the era of reduced-intensity conditioning

DS Subramaniam, DH Fowler, SZ Pavletic - Leukemia, 2007 - nature.com
In the past decade the field of hematopoietic stem cell transplantation has entered a new era
with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on …

Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation

M Döring, KM Rohrer, A Erbacher, F Gieseke… - Annals of …, 2015 - Springer
The human leukocyte antigen DR surface expression on CD14+ monocytes reflects the
degree to which these cells have been activated. Given the central role monocytes and …